Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.
暂无分享,去创建一个
[1] J. Szostak,et al. In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.
[2] Robert Langer,et al. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers , 2008, Proceedings of the National Academy of Sciences.
[3] Georg Sczakiel,et al. Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. , 2002, Nucleic acids research.
[4] Weihong Tan,et al. Cancer cell targeting using multiple aptamers conjugated on nanorods. , 2008, Analytical chemistry.
[5] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[6] R. Jain,et al. Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.
[7] Joshua E. Smith,et al. Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. , 2008, Analytical chemistry.
[8] G. Mayer,et al. Multidomain Targeting Generates a High‐Affinity Thrombin‐Inhibiting Bivalent Aptamer , 2007, Chembiochem : a European journal of chemical biology.
[9] Weihong Tan,et al. Cell-specific internalization study of an aptamer from whole cell selection. , 2008, Chemistry.
[10] Weihong Tan,et al. Identification of liver cancer-specific aptamers using whole live cells. , 2008, Analytical chemistry.
[11] Andrew D Ellington,et al. Aptamer:toxin conjugates that specifically target prostate tumor cells. , 2006, Cancer research.
[12] Andrew D. Ellington,et al. Aptamer mediated siRNA delivery , 2006, Nucleic acids research.
[13] Hui Chen,et al. Molecular recognition of acute myeloid leukemia using aptamers , 2008, Leukemia.
[14] Xiaoling Zhang,et al. Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells , 2009, Chembiochem : a European journal of chemical biology.
[15] Kemin Wang,et al. Selection of aptamers for molecular recognition and characterization of cancer cells. , 2007, Analytical chemistry.
[16] M L Yarmush,et al. Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Shangguan,et al. Aptamer Directly Evolved from Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain in Burkitt's Lymphoma Cells*S , 2007, Molecular & Cellular Proteomics.
[18] M. Famulok,et al. Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy , 2007 .
[19] H. Schluesener,et al. Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels , 2001, The Journal of Biological Chemistry.
[20] Weihong Tan,et al. Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. , 2009, Analytical chemistry.
[21] Mukesh Verma,et al. The promise of biomarkers in cancer screening and detection. , 2002, Trends in molecular medicine.
[22] David Allman,et al. Regulation of peripheral B cell maturation. , 2006, Cellular immunology.
[23] Paul M. Schneider,et al. High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets , 2004, Clinical Cancer Research.
[24] Ariel D. Anbar,et al. Aptamers Evolved from Cultured Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient Samples , 2007 .
[25] Weihong Tan,et al. Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[26] J. M. Healy,et al. Complex Target SELEX , 2008 .
[27] J. Yates,et al. The application of mass spectrometry to membrane proteomics , 2003, Nature Biotechnology.
[28] Yingfu Li,et al. Nucleic acid aptamers and enzymes as sensors. , 2006, Current opinion in chemical biology.
[29] Sergey N Krylov,et al. Aptamer-facilitated biomarker discovery (AptaBiD). , 2008, Journal of the American Chemical Society.
[30] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[31] Michael Famulok,et al. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. , 2008, Angewandte Chemie.
[32] Zhiwen Tang,et al. Cell Specific Aptamer–Photosensitizer Conjugates as a Molecular Tool in Photodynamic Therapy , 2008, ChemMedChem.
[33] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[34] Koji Sode,et al. Improvement of Aptamer Affinity by Dimerization , 2008, Sensors.
[35] Weihong Tan,et al. Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers , 2008, ChemMedChem.
[36] Joshua E. Smith,et al. Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. , 2007, Analytical chemistry.
[37] D. S. Coffey,et al. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. , 2002, Cancer research.
[38] 杨朝勇. Aptamers evolved from live cells as effective molecular probes for cancer study , 2006 .
[39] L. Gold,et al. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[40] Chunli Bai,et al. Specific aptamer-protein interaction studied by atomic force microscopy. , 2003, Analytical chemistry.
[41] L. Kèlland,et al. Discovery and development of anticancer aptamers , 2006, Molecular Cancer Therapeutics.
[42] Kit S Lam,et al. From combinatorial chemistry to cancer-targeting peptides. , 2007, Molecular pharmaceutics.
[43] Giuliano Mazzini,et al. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications , 2011, Expert review of molecular diagnostics.
[44] K Okinaga,et al. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele‐specific amplification of p53 and K‐ras genes in patients with colorectal cancer , 2000, International journal of cancer.
[45] Weihong Tan,et al. Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. , 2006, Analytical chemistry.
[46] A D Ellington,et al. Aptamers as therapeutic and diagnostic reagents: problems and prospects. , 1997, Current opinion in chemical biology.
[47] Omid C. Farokhzad,et al. Nanoparticle-Aptamer Bioconjugates , 2004, Cancer Research.
[48] Bertrand Tavitian,et al. Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase , 2005, PLoS biology.
[49] Gerhard Ziemer,et al. A New Technique for the Isolation and Surface Immobilization of Mesenchymal Stem Cells from Whole Bone Marrow Using High‐Specific DNA Aptamers , 2006, Stem cells.
[50] T. Ogihara,et al. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[51] Weihong Tan,et al. Molecular assembly for high-performance bivalent nucleic acid inhibitor , 2008, Proceedings of the National Academy of Sciences.
[52] Weihong Tan,et al. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. , 2008, Journal of proteome research.